Sugi Holdings Co.,Ltd.

7649.T
Pharmaceutical Retailers
2026/07/09 Updated
Market Cap: $3.7B (¥594.9B)
Stock Price: $20.22 (¥3,287)
Exchange Rate: 1 USD = ¥162.60

Q1 FY2027 Financial Summary (Japan GAAP) (Consolidated)

For the first quarter of FY2027, consolidated net sales were 27,017.5 million yen (up 10.1% YoY), operating income was 12,214 million yen, net income attributable to owners of parent for the quarter was 6,901 million yen, and the company intends to maintain its dividend policy including a share split, with full-year guidance unchanged from the previous release. Store expansion and renovations, and strengthening of the dispensing/retail segment continue.

Importance:
Page Updated: July 9, 2026
IR Disclosure Date: July 9, 2026

Key Figures

  • Net Sales: 270,175百万円
  • Operating Income: 12,209百万円
  • Net Income Attributable to Owners of Parent: 6,901百万円

AI要約

Overview of Results

Sugiholding Holdings achieved net sales of 27,017.5 hundred million yen in Q1, up 10.1% YoY. EBITDA was 17,069 million yen, and operating income was 12,209 million yen. Net income attributable to owners of parent for the quarter decreased significantly to 6,901 million yen (YoY △67.5%); this was due to the additional deferred tax asset effects from the absorption-type merger with I&H Co., Ltd. The segment is a single segment of drugstore and dispensing services, with ongoing store expansion, renovations, private-brand expansion, and data-driven promotions.

Outlook and Capital Policy

Full-year consolidated earnings guidance remains unchanged from the forecast announced in April 2026, with a planned share split on September 1, 2026. The year-end dividend is expected to be 35 yen per share (post-split basis according to company plan), though the actual post-split dividend remains undecided; please refer to the note. The impact of new share issuance and subsidiary acquisition (Sekiyaku) is currently under review.

Sugiholding Holdings Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →